Abstract
Myeloid differentiation is a highly regulated process governed by various cytokines, such as EPO, TPO, G-CSF, IL-3, IL-5 and GM-CSF. These cytokines act in part through activation of the STAT transcription factor family. In particular, various isoforms of STAT3 and STAT5 are activated during myeloid differentiation in a cell-type and maturation-state dependent fashion. In vitro studies have shown that STAT proteins are essential for cytokine-regulated processes such as cellular proliferation, differentiation as well as survival. Similarly, various STAT knock-outs have highlighted the role of STATs in myeloid differentiation in vivo. STATs also appear to play an important role in various myeloid malignancies, which are characterized by arrested maturation and cytokine-independent proliferation of myeloid progenitors. Constitutive activation of STAT3 and/or STAT5 resulting in enhanced transcription of anti-apoptotic- cell-cycle progression genes is likely to contribute to the pathogenesis of various myeloid leukemia's.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Afar DE, Goga A, McLaughlin J, Witte ON and Sawyers CL . 1994 Science 264: 424–426
Afar DE, McLaughlin J, Sherr CJ, Witte ON and Roussel MF . 1995 Proc Natl Acad Sci USA 92: 9540–9544
Al-Shami A, Mahanna W and Naccache PH . 1998 J Biol Chem 273: 1058–1063
Amarante-Mendes GP, McGahon AJ, Nishioka WK, Afar DE, Witte ON and Green DR . 1998a Oncogene 16: 1383–1390
Amarante-Mendes GP, Naekyung KC, Liu L, Huang Y, Perkins CL, Green DR and Bhalla K . 1998b Blood 91: 1700–1705
Arnould C, Philippe C, Bourdon V, Gregoire MJ, Berger R and Jonveaux P . 1999 Hum Mol Genet 8: 1741–1749
Aronica MG, Brizzi MF, Dentelli P, Rosso A, Yarden Y and Pegoraro L . 1996 Oncogene 13: 1017–1026
Azam M, Erdjument-Bromage H, Kreider BL, Xia M, Quelle F, Basu R, Saris C, Tempst P, Ihle JN and Schindler C . 1995 EMBO J 14: 1402–1411
Azam M, Lee C, Strehlow I and Schindler C . 1997 Immunity 6: 691–701
Belhoussine R, Morjani H, Gillet R, Palissot V and Manfait M . 1999 Adv Exp Med Biol 457: 365–381
Biethahn S, Alves F, Wilde S, Hiddemann W and Spiekermann K . 1999 Exp Hematol 27: 885–894
Boeuf H, Hauss C, Graeve FD, Baran N and Kedinger C . 1997 J Cell Biol 138: 1207–1217
Bovolenta C, Gasperini S and Cassatella MA . 1996 FEBS Lett 386: 239–242
Bromberg JF, Horvath CM, Besser D, Lathem WW and Darnell JEJ . 1998 Mol Cell Biol 18: 2553–2558
Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell JEJ . 1999 Cell 98: 295–303
Caldenhoven E, Coffer P, Yuan J, van de Stolpe A, Horn F, Kruijer W and van der Saag PT . 1994 J Biol Chem 269: 21146–21154
Caldenhoven E, van Dijk TB, Solari R, Armstrong J, Raaijmakers JAM, Lammers JWJ, Koenderman L and De Groot RP . 1996 J Biol Chem 271: 13221–13227
Caldenhoven E, van Dijk TB, Tijmensen A, Raaijmakers JA, Lammers JW, Koenderman L and De Groot RP . 1998 Stem Cells 16: 397–403
Caldenhoven E, van Dijk T, Raaijmakers JAM, Lammers JWJ, Koenderman L and De Groot RP . 1999a Mol Cell Biol Res Comm 1: 95–101
Caldenhoven E, Buitenhuis M, van Dijk T, Raaijmakers JAM, Lammers JWJ, Koenderman L and De Groot RP . 1999b J Leukoc Biol 65: 391–369
Cao X, Tay A, Guy GR and Tan YH . 1996 Mol Cell Biol 16: 1595–1603
Carlesso N, Frank DA and Griffin JD . 1996 J Exp Med 183: 811–820
Carroll M, Zhu Y and D'Andrea AD . 1995 Proc Natl Acad Sci USA 92: 2869–2873
Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton WS and Jove R . 1999 Immunity 10: 105–115
Chai SK, Nichols GL and Rothman P . 1997 J Immunol 159: 4720–4728
Chakraborty A, White SM, Schaefer TS, Ball ED, Dyer KF and Tweardy DJ . 1996 Blood 88: 2442–2449
Chakraborty A and Tweardy DJ . 1998a J Leukoc Biol 64: 675–680
Chakraborty A and Tweardy DJ . 1998b Leuk Lymphoma 30: 433–442
Chakraborty A, Alarcon MH, White SM and Tweardy DJ . 1999 Blood 94 Suppl1: 471a
Chaturvedi P, Sharma S and Reddy EP . 1997 Mol Cell Biol 17: 3295–3304
Chaturvedi P, Reddy MV and Reddy EP . 1998 Oncogene 16: 1749–1758
Chretien S, Varlet P, Verdier F, Gobert S, Cartron JP, Gisselbrecht S, Mayeux P and Lacombe C . 1996 EMBO J 15: 4174–4181
Daley GQ, McLaughlin J, Witte ON and Baltimore D . 1987 Science 237: 532–535
Daley GQ and Baltimore D . 1988 Proc Natl Acad Sci USA 85: 9312–9316
Damen JE, Wakao H, Miyajima A, Krosl J, Humphries RK, Cutler RL and Krystal G . 1995 EMBO J 14: 5557–5568
De Groot RP, Coffer PJ and Koenderman L . 1998 Cell Signal 10: 619–628
De Groot RP, Raaijmakers JA, Lammers JW, Jove R and Koenderman L . 1999 Blood 94: 1108–1112
Dorsch M, Fan PD, Danial NN, Rothman PB and Goff SP . 1997 J Exp Med 186: 1947–1955
Dorsch M, Danial NN, Rothman PB and Goff SP . 1999 Blood 94: 2676–2685
Dumon S, Santos SC, Debierre-Grockiego F, Gouilleux-Gruart V, Cocault L, Boucheron C, Mollat P, Gisselbrecht S and Gouilleux F . 1999 Oncogene 18: 4191–4199
Durbin JE, Hackenmiller R, Simon MC and Levy DE . 1996 Cell 84: 443–450
Feldman GM, Rosenthal LA, Liu X, Hayes MP, Wynshaw-Boris A, Leonard WJ, Hennighausen L and Finbloom DS . 1997 Blood 90: 1768–1776
Frank DA and Varticovski L . 1996 Leukemia 10: 1724–1730
Fukada T, Ohtani T, Yoshida Y, Shirogane T, Nishida K, Nakajima K, Hibi M and Hirano T . 1998 EMBO J 17: 6670–6677
Garcia R and Jove R . 1998 J Biomed Sci 5: 79–85
Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse JF, Capiod JC, Delobel J, Weber-Nordt R, Dusanter-Fourt I, Dreyfus F, Groner B and Prin L . 1996 Blood 87: 1692–1697
Hamasaki A, Sendo F, Nakayama K, Ishida N, Negishi I, Nakayama K and Hatakeyama S . 1998 J Exp Med 188: 1985–1992
Hayakawa F, Towatari M, Iida H, Wakao H, Kiyoi H, Naoe T and Saito H . 1998 Br J Haematol 101: 521–528
Hoffman-Liebermann B and Liebermann DA . 1991 Oncogene 6: 903–909
Ilaria RLJ and Van Etten RA . 1996 J Biol Chem 271: 31704–31710
Ilaria RLJ, Hawley RG and Van Etten RA . 1999 Blood 93: 4154–4166
Iwatsuki K, Endo T, Misawa H, Yokouchi M, Matsumoto A, Ohtsubo M, Mori KJ and Yoshimura A . 1997 J Biol Chem 272: 8149–8152
Jiang H, Lin J, Su ZZ, Collart FR, Huberman E and Fisher PB . 1994 Oncogene 9: 3397–3406
Kaplan MH, Sun YL, Hoey T and Grusby MJ . 1996a Nature 382: 174–177
Kaplan MH, Schindler U, Smiley ST and Grusby MJ . 1996b Immunity 4: 313–319
Kaplan MH, Daniel C, Schindler U and Grusby MJ . 1998 Mol Cell Biol 18: 1996–2003
Kazansky AV, Raught B, Lindsey SM, Wang YF and Rosen JM . 1995 Mol Endocrinol 9: 1598–1609
Kirito K, Uchida M, Yamada M, Miura Y and Komatsu N . 1997 J Biol Chem 272: 16507–16513
Kirito K, Uchida M, Takatoku M, Nakajima K, Hirano T, Miura Y and Komatsu N . 1998 Blood 92: 462–471
Kiuchi N, Nakajima K, Ichiba M, Fukada T, Narimatsu M, Mizuno K, Hibi M and Hirano T . 1999 J Exp Med 189: 63–73
Klingmuller U, Wu H, Hsiao JG, Toker A, Duckworth BC, Cantley LC and Lodish HF . 1997 Proc Natl Acad Sci USA 94: 3016–3021
Krosl J, Damen JE, Krystal G and Humphries RK . 1996 J Biol Chem 271: 27432–27437
Kruger A and Anderson SM . 1991 Oncogene 6: 245–256
Lamb P, Seidel HM, Haslam J, Milocco L, Kessler LV, Stein RB and Rosen J . 1995 Nucleic Acids Res 23: 3283–3289
Lee C, Piazza F, Brutsaert S, Valens J, Strehlow I, Jarosinski M, Saris C and Schindler C . 1999 J Biol Chem 274: 26767–26775
Leonard WJ and O'Shea JJ . 1998 Annu Rev Immunol 16: 293–322
Lieschke GJ, Grail D, Hodgson G, Metcalf D, Stanley E, Cheers C, Fowler KJ, Basu S, Zhan YF and Dunn AR . 1994 Blood 84: 1737–1746
Lin EY, Orlofsky A, Wang HG, Reed JC and Prystowsky MB . 1996 Blood 87: 983–992
Liu KD, Gaffen SL and Goldsmith MA . 1998 Curr Opin Immunol 10: 271–278
Liu X, Robinson GW, Gouilleux F, Groner B and Hennighausen L . 1995 Proc Natl Acad Sci USA 92: 8831–8835
Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A and Hennighausen L . 1997 Genes Dev 11: 179–186
Lokuta MA, McDowell MA and Paulnock DM . 1998 J Immunol 161: 1594–1597
Lowenberg B and Touw IP . 1993 Blood 81: 281–292
Matsumoto A, Masuhara M, Mitsui K, Yokouchi M, Ohtsubo M, Misawa H, Miyajima A and Yoshimura A . 1997 Blood 89: 3148–3154
Matsumura I, Ishikawa J, Nakajima K, Oritani K, Tomiyama Y, Miyagawa J, Kato T, Miyazaki H, Matsuzawa Y and Kanakura Y . 1997 Mol Cell Biol 17: 2933–2943
Matsumura I, Kitamura T, Wakao H, Tanaka H, Hashimoto K, Albanese C, Downward J, Pestell RG and Kanakura Y . 1999 EMBO J 18: 1367–1377
Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M and Schreiber RD . 1996 Cell 84: 431–442
Meyer J, Jucker M, Ostertag W and Stocking C . 1998 Blood 91: 1901–1908
Minami M, Inoue M, Wei S, Takeda K, Matsumoto M, Kishimoto T and Akira S . 1996 Proc Natl Acad Sci USA 93: 3963–3966
Moriggl R, Gouilleux-Gruart V, Jahne R, Berchtold S, Gartmann C, Liu X, Hennighausen L, Sotiropoulos A, Groner B and Gouilleux F . 1996 Mol Cell Biol 16: 5691–5700
Moriggl R, Sexl V, Pickorz R, Topham D and Ihle JH . 1999 Immunity 11: 225–230
Mui AL, Wakao H, Kinoshita T, Kitamura T and Miyajima A . 1996 EMBO J 15: 2425–2433
Mui AL . 1999 Cell Mol Life Sci 55: 1547–1558
Naik SM, Shibagaki N, Li LJ, Quinlan KL, Paxton LL and Caughman SW . 1997 J Biol Chem 272: 1283–1290
Nakajima K, Yamanaka Y, Nakae K, Kojima H, Ichiba M, Kiuchi N, Kitaoka T, Fukada T, Hibi M and Hirano T . 1996 EMBO J 15: 3651–3658
Narimatsu M, Nakajima K, Ichiba M and Hirano T . 1997 Biochem Biophys Res Commun 238: 764–768
Nieborowska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B and Skorski T . 1999 J Exp Med 189: 1229–1242
Niu G, Heller R, Catlett-Falcone R, Coppola D, Jaroszeski M, Dalton W, Jove R and Yu H . 1999 Cancer Res 59: 5059–5063
Nosaka T, Kawashima T, Misawa K, Ikuta K, Mui AL and Kitamura T . 1999 EMBO J 18: 4754–4765
Ogawa M . 1993 Blood 81: 2844–2853
Onishi M, Nosaka T, Misawa K, Mui AL, Gorman D, McMahon M, Miyajima A and Kitamura T . 1998 Mol Cell Biol 18: 3871–3879
Orlofsky A, Somogyi RD, Weiss LM and Prystowsky MB . 1999 J Immunol 163: 412–419
Pinto A, Zulian GB and Archimbaud E . 1998 Crit Rev Oncol Hematol 27: 161–164
Reed JC . 1998 Oncogene 17: 3225–3236
Ripperger JA, Fritz S, Richter K, Hocke GM, Lottspeich F and Fey GH . 1995 J Biol Chem 270: 29998–30006
Rosen RL, Winestock KD, Chen G, Liu X, Hennighausen L and Finbloom DS . 1996 Blood 88: 1206–1214
Rowley JD . 1973 Nature 243: 290–293
Sasse J, Hemmann U, Schwartz C, Schniertshauer U, Heesel B, Landgraf C, Schneider-Mergener J, Heinrich PC and Horn F . 1997 Mol Cell Biol 17: 4677–4686
Sattler M and Salgia R . 1997 Cytokine Growth Factor Rev 8: 63–79
Sawyers CL, Callahan W and Witte ON . 1992 Cell 70: 901–910
Schaefer TS, Sanders LK and Nathans D . 1995 Proc Natl Acad Sci USA 92: 9097–9101
Schaefer TS, Sanders LK, Park OK and Nathans D . 1997 Mol Cell Biol 17: 5307–5316
Schuringa JJ, Wieringa B-J, Kruijer W and Vellenga E . 1999 Blood 94 Suppl 1: 475a
Seidel HM, Milocco LH, Lamb P, Darnell JEJ, Stein RB and Rosen J . 1995 Proc Natl Acad Sci USA 92: 3041–3045
Selvakumaran M, Liebermann DA and Hoffman-Liebermann B . 1992 Mol Cell Biol 12: 2493–2500
Sherr CJ and Roberts JM . 1999 Genes Dev 13: 1501–1512
Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DA, Doherty PC, Grosveld G, Paul WE and Ihle JN . 1996 Nature 380: 630–633
Shimozaki K, Nakajima K, Hirano T and Nagata S . 1997 J Biol Chem 272: 25184–25189
Shuai K, Halpern J, ten Hoeve J, Rao X and Sawyers CL . 1996 Oncogene 13: 247–254
Smithgall TE . 1998 Pharmacol Rev 50: 1–19
Socolovsky M, Fallon AE, Wang S, Brugnara C and Lodish HF . 1999 Cell 98: 181–191
Stewart MJ, Litz-Jackson S, Burgess GS, Williamson EA, Leibowitz DS and Boswell HS . 1995 Leukemia 9: 1499–1507
Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T and Akira S . 1996 Nature 380: 627–630
Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T and Akira S . 1997 Proc Natl Acad Sci USA 94: 3801–3804
Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Forster I and Akira S . 1999 Immunity 10: 39–49
Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G and Ihle JN . 1998 Cell 93: 841–850
Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DA, Doherty PC, Grosveld GC and Ihle JN . 1996 Nature 382: 171–174
Turkson J, Bowman T, Adnane J, Zhang Y, Djeu JY, Sekharam M, Frank DA, Holzman LB, Wu J, Sebti S and Jove R . 1999 Mol Cell Biol 19: 7519–7528
Turkson J, Bowman T, Garcia R, Caldenhoven E, De Groot RP and Jove R . 1998 Mol Cell Biol 18: 2545–2552
Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ and Davey HW . 1997 Proc Natl Acad Sci USA 94: 7239–7244
van der Bruggen T, Caldenhoven E, Kanters D, Coffer P, Raaijmakers JA, Lammers JW and Koenderman L . 1995 Blood 85: 1442–1448
Verdier F, Rabionet R, Gouilleux F, Beisenherz-Huss C, Varlet P, Muller O, Mayeux P, Lacombe C, Gisselbrecht S and Chretien S . 1998 Mol Cell Biol 18: 5852–5860
Wang D, Stravopodis D, Teglund S, Kitazawa J and Ihle JN . 1996 Mol Cell Biol 16: 6141–6148
Ward AC, Hermans MH, Smith L, van Aesch YM, Schelen AM, Antonissen C and Touw IP . 1999a Blood 93: 113–124
Ward AC, Smith L, de Koning JP, van Aesch Y and Touw IP . 1999b J Biol Chem 274: 14956–14962
Weber-Nordt RM, Egen C, Wehinger J, Ludwig W, Gouilleux-Gruart V, Mertelsmann R and Finke J . 1996 Blood 88: 809–816
Weber-Nordt RM, Gabler A, Janson C, Weber F and Ho AD . 1999 Blood 94 Suppl 1: 75a
Welte T, Koch F, Schuler G, Lechner J, Doppler W and Heufler C . 1997 Eur J Immunol 27: 2737–2740
Wen Z, Zhong Z and Darnell JEJ . 1995 Cell 82: 241–250
Williamson EA, Burgess GS, Eder P, Litz-Jackson S and Boswell HS . 1997 Leukemia 11: 73–85
Woldman I, Mellitzer G, Kieslinger M, Buchhart D, Meinke A, Beug H and Decker T . 1997 J Immunol 159: 877–886
Xia Z, Baer MR, Block AW, Baumann H and Wetzler M . 1998 Cancer Res 58: 3173–3180
Yamada H, Iwase S, Nagai M, Nemoto T, Sekikawa T, Takahara S, Nakada S, Furukawa Y and Horiguchi-Yamada J . 1996 Int J Hematol 65: 31–40
Yamamoto K, Quelle FW, Thierfelder WE, Kreider BL, Gilbert DJ, Jenkins NA, Copeland NG, Silvennoinen O and Ihle JN . 1994 Mol Cell Biol 14: 4342–4349
Yamanaka Y, Nakajima K, Fukada T, Hibi M and Hirano T . 1996 EMBO J 15: 1557–1565
Yamashita H, Xu J, Erwin RA, Farrar WL, Kirken RA and Rui H . 1998 J Biol Chem 273: 30218–30224
Yoshimura A . 1998 Leukemia 12: 1851–1857
Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J and Jove R . 1995 Science 269: 81–83
Acknowledgements
P Coffer is supported by a research grant from GlaxoWellcome. RP de Groot is supported by a fellowship from the Royal Netherlands Academy of Arts and Sciences.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Coffer, P., Koenderman, L. & de Groot, R. The role of STATs in myeloid differentiation and leukemia. Oncogene 19, 2511–2522 (2000). https://doi.org/10.1038/sj.onc.1203479
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203479
Keywords
This article is cited by
-
STAT3 phosphorylation in central leptin resistance
Nutrition & Metabolism (2021)
-
Targeting cancer cell plasticity by HDAC inhibition to reverse EBV-induced dedifferentiation in nasopharyngeal carcinoma
Signal Transduction and Targeted Therapy (2021)
-
STAT5-dependent regulation of CDC25A by miR-16 controls proliferation and differentiation in FLT3-ITD acute myeloid leukemia
Scientific Reports (2020)
-
Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives
Molecular Diagnosis & Therapy (2019)
-
The phosphatase PPM1A controls monocyte-to-macrophage differentiation
Scientific Reports (2018)